Dupont Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-131,529
Closed -$13.1M 1346
2019
Q3
$13.1M Sell
131,529
-4,096
-3% -$389K 0.3% 55
2019
Q2
$12.5M Sell
135,625
-22,435
-14% -$2.13M 0.29% 67
2019
Q1
$14.9M Buy
158,060
+19,658
+14% +$1.72M 0.34% 50
2018
Q4
$8.87M Sell
138,402
-65,732
-32% -$4.85M 0.22% 80
2018
Q3
$18.3M Buy
204,134
+23,307
+13% +$2.06M 0.4% 41
2018
Q2
$14.4M Buy
180,827
+1,544
+0.9% +$128K 0.34% 53
2018
Q1
$16M Sell
179,283
-30,369
-14% -$2.92M 0.39% 43
2017
Q4
$21.9M Buy
209,652
+10,094
+5% +$1.14M 0.5% 27
2017
Q3
$29.1M Sell
199,558
-4,232
-2% -$576K 0.66% 19
2017
Q2
$26.5M Buy
203,790
+26,038
+15% +$3.19M 0.59% 22
2017
Q1
$22.1M Sell
177,752
-44,244
-20% -$5.29M 0.49% 32
2016
Q4
$25.7M Buy
221,996
+4,791
+2% +$534K 0.57% 24
2016
Q3
$22.7M Buy
217,205
+54,197
+33% +$5.87M 0.51% 26
2016
Q2
$16.1M Sell
163,008
-6,508
-4% -$673K 0.36% 53
2016
Q1
$17M Buy
169,516
+14,200
+9% +$1.46M 0.39% 54
2015
Q4
$18.6M Sell
155,316
-61,639
-28% -$7.13M 0.45% 41
2015
Q3
$23.5M Sell
216,955
-117,687
-35% -$14.6M 0.59% 33
2015
Q2
$38.7M Sell
334,642
-11,461
-3% -$1.31M 0.84% 22
2015
Q1
$39.9M Sell
346,103
-108,703
-24% -$13M 0.78% 21
2014
Q4
$50.9M Sell
454,806
-41,689
-8% -$4.4M 0.94% 21
2014
Q3
$47.1M Sell
496,495
-42,745
-8% -$3.86M 0.82% 19
2014
Q2
$46.3M Buy
539,240
+80,374
+18% +$6.11M 0.76% 23
2014
Q1
$32M Buy
458,866
+40,670
+10% +$3.22M 0.52% 31
2013
Q4
$35.3M Sell
418,196
-18,734
-4% -$1.48M 0.62% 25
2013
Q3
$33.6M Buy
436,930
+90,468
+26% +$6.34M 0.62% 23
2013
Q2
$20.3M Buy
+346,462
New +$20.8M 0.38% 56

Other funds holding CELG

Dupont Capital Management's CELG Position: Q4 2019 in Review

Dupont Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 131,529 shares — an estimated $13.1M sold.

Dupont Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $50.9M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Dupont Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Dupont Capital Management sold 131,529 Celgene Corp shares in Q4 2019, an estimated $13.1M.
  • Dupont Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Dupont Capital Management's Celgene Corp position peaked at $50.9M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Dupont Capital Management's 13F filing for Q4 2019, filed 27 Jan 2020.